CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells

被引:63
作者
Cerutti, A
Schaffer, A
Shah, S
Zan, H
Liou, HC
Goodwin, RG
Casali, P [1 ]
机构
[1] Cornell Univ, Coll Med, Dept Pathol, Div Mol Immunol, New York, NY 10021 USA
[2] Cornell Univ, Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA
[3] Cornell Univ, Coll Med, Dept Med, Div Immunol, New York, NY 10021 USA
[4] Immunex Corp, Seattle, WA 98101 USA
关键词
D O I
10.1016/S1074-7613(00)80607-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We used our monoclonal model of germinal center maturation, CL-01 B cells, to investigate the role of CD30 in human B cell differentiation. CL-01 cells are IgM(+)IgD(+)CD30(+) and switch to IgG, IgA, and IgE when exposed to CD40L and IL-4. Switching is hampered by CD30 coengagement, possibly through interference with the CD40-mediated NF-kappa B-dependent transcriptional activation of downstream C-H genes. The physiological relevance of this phenomenon is emphasized by similar CD30-mediated effects in naive B cells. Expression of CD30 by these cells is induced by CD40L but is inhibited by B cell receptor coengagement and/or exposure to IL-6 and IL-12. Our data suggest that CD30 critically regulates the CD40-mediated differentiation of non-antigen-selected human B cells.
引用
收藏
页码:247 / 256
页数:10
相关论文
共 46 条
  • [21] TRAF-interacting protein (TRIP): A novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappa B activation
    Lee, SY
    Lee, SY
    Choi, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07) : 1275 - 1285
  • [22] Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6
    Morse, L
    Chen, DQ
    Franklin, D
    Xiong, Y
    ChenKiang, S
    [J]. IMMUNITY, 1997, 6 (01) : 47 - 56
  • [23] Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cells
    Mueller, CGF
    Rissoan, MC
    Salinas, B
    AitYahia, S
    Ravel, O
    Bridon, JM
    Briere, F
    Lebecque, S
    Liu, YJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (05) : 655 - 663
  • [24] Structure and function of a new STAT-induced STAT inhibitor
    Naka, T
    Narazaki, M
    Hirata, M
    Matsumoto, T
    Minamoto, S
    Aono, A
    Nishimoto, N
    Kajita, T
    Taga, T
    Yoshizaki, K
    Akira, S
    Kishimoto, T
    [J]. NATURE, 1997, 387 (6636) : 924 - 929
  • [25] Co-receptors of B lymphocytes
    ORourke, L
    Tooze, R
    Fearon, DT
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (03) : 324 - 329
  • [26] ACTIVATED T-CELLS INDUCE EXPRESSION OF B7/BB1 ON NORMAL OR LEUKEMIC B-CELLS THROUGH A CD40-DEPENDENT SIGNAL
    RANHEIM, EA
    KIPPS, TJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) : 925 - 935
  • [27] Identification and characterization of an I kappa B kinase
    Regnier, CH
    Song, HY
    Gao, X
    Goeddel, DV
    Cao, ZD
    Rothe, M
    [J]. CELL, 1997, 90 (02) : 373 - 383
  • [28] I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction
    Rothe, M
    Xiong, J
    Shu, HB
    Williamson, K
    Goddard, A
    Goeddel, DV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) : 8241 - 8246
  • [29] TRAF2-MEDIATED ACTIVATION OF NF-KAPPA-B BY TNF RECEPTOR-2 AND CD40
    ROTHE, M
    SARMA, V
    DIXIT, VW
    GOEDDEL, DV
    [J]. SCIENCE, 1995, 269 (5229) : 1424 - 1427
  • [30] Schaffer A, 1998, FASEB J, V12, pA1058